Literature DB >> 3892008

A sialic-acid-specific lectin from Cepaea hortensis that promotes phagocytosis of a group-B, type-Ia, streptococcal strain.

S E Holm, A M Bergholm, B Wagner, M Wagner.   

Abstract

Group-B streptococci that possess a type-specific surface polysaccharide undergo phagocytosis only in the presence of antibodies to this, and complement. The snail Cepaea hortensis forms a lectin that is specific for sialic acid; treatment with this promoted the phagocytosis of a group-B streptococcus of serotype Ia (strain O90) in the absence of opsonic antibodies. The effect of the lectin was dose-dependent and required the presence of complement. The specificity of the lectin reaction for sialic acid was proved by the inhibition of phagocytosis by bovine submaxillary mucin. The participation of complement in the reaction was confirmed by demonstrating that C3 was bound to the surface of lectin-treated cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3892008     DOI: 10.1099/00222615-19-3-317

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

Review 2.  Lectins and their application to clinical microbiology.

Authors:  M Slifkin; R J Doyle
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

Review 3.  Sialic acid binding lectins.

Authors:  C Mandal; C Mandal
Journal:  Experientia       Date:  1990-05-15

4.  Identification of group B streptococcal antigen with lectin-bound polystyrene particles.

Authors:  M Slifkin; R Cumbie
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

5.  Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).

Authors:  C von Hunolstein; S D'Ascenzi; B Wagner; J Jelínková; G Alfarone; S Recchia; M Wagner; G Orefici
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.